ArticleFrontiers in oncology2025

Trial in progress: phase I study of non-viral gene-modified CAR-T cell therapy for malignant solid tumors expressing EPHB4 receptor (CARTiEr).

Chikako Funasaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.